AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimza MF 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Lifevision Healthcare

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimza MF 2mg/500mg Tablet SR

This medication, Glimza MF 2mg/500mg SR tablets, is an antidiabetic combination therapy for adult patients with type 2 diabetes. It manages blood glucose levels by combining two active ingredients. Always take this medication with food, consistently at the same time daily for optimal results. Dosage is determined and adjusted by your physician based on your blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can lead to elevated glucose, potentially causing kidney complications, vision loss, neuropathy, and limb amputation. This medication is one component of a comprehensive diabetes management plan; a healthy diet, exercise, and weight management, as directed by your doctor, are also vital. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to treat them promptly. Regular meals and carrying a fast-acting glucose source (e.g., sugary snacks, fruit juice) are preventative measures. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain may also occur. This medicine is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Glimza MF 2mg/500mg Tablet SR

No text provided. Please provide the text you want me to rephrase.

Uses of Glimza MF 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimza MF 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimza MF 2mg/500mg Tablet SR whole; do not crush, chew, or divide it. Administer this extended-release tablet with a meal.

Common Side effects of Glimza MF 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimza MF 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimza MF 2mg/500mg Tablet SR whole; do not alter its form by chewing, crushing, or breaking. Administer this extended-release tablet with a meal.

How Glimza MF 2mg/500mg Tablet SR works:

Glimza MF 2mg/500mg extended-release tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimza MF 2mg/500mg SR tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimza MF 2mg/500mg Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Sustained-release Glimza MF 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired if your blood glucose level is either abnormally low or elevated. Refrain from driving if such symptoms manifest.

KidneyKidneyCAUTION

Exercise caution when prescribing Glimza MF 2mg/500mg Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician before administering. Avoid using Glimza MF 2mg/500mg Tablet SR in patients exhibiting severe kidney disease. Regular assessment of kidney function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should exercise caution when using Glimza MF 2mg/500mg Tablet SR. Dosage modification of Glimza MF 2mg/500mg Tablet SR may be necessary. Medical advice is recommended. For patients experiencing mild to moderate liver disease, Glimza MF 2mg/500mg Tablet SR is typically initiated at a low dosage; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Glimza MF 2mg/500mg Tablet SR :

Should you forget a dose of Glimza MF 2mg/500mg SR Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimza MF 2mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Medication

FAQs on Glimza MF 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimza MF 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimza MF 2mg/500mg Tablet SR and seek immediate medical attention.
Glimza MF 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimza MF 2mg/500mg SR Tablets may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use can result in vitamin B12 deficiency.
Prolonged Glimza MF 2mg/500mg Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimza MF 2mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimza MF 2mg/500mg SR tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimza MF 2mg/500mg Table...
154
MRP 178
13% off